Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2022 Nov 14;43(11):889-896.
doi: 10.3760/cma.j.issn.0253-2727.2022.11.002.

[Chinese guideline for diagnosis and treatment of transfusion dependent β-thalassemia (2022)]

[Article in Chinese]
Red Blood Cell Diseases (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association
Practice Guideline

[Chinese guideline for diagnosis and treatment of transfusion dependent β-thalassemia (2022)]

[Article in Chinese]
Red Blood Cell Diseases (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association. Zhonghua Xue Ye Xue Za Zhi. .
No abstract available

PubMed Disclaimer

Figures

图1
图1. β地中海贫血中游离α珠蛋白肽链过剩产生的影响
图2
图2. 地中海贫血诊断流程图
注　MCH：红细胞平均血红蛋白；MCV：红细胞平均体积；HPLC：高效液相色谱；ZnPP：锌原卟啉
图3
图3. 地中海贫血的诊断方法总结（HbE/β地贫：血红蛋白E/β地贫）
图4
图4. 地中海贫血患者祛铁治疗方案
注 SF：血清铁蛋白；DFO：去铁胺；DFP：去铁酮；DFX：地拉罗司
See this image and copyright information in PMC

References

    1. 陈 耀龙, 李 幼平, 杜 亮, et al. 医学研究中证据分级和推荐强度的演进[J] 中国循证医学杂志. 2008;8(2):127–133. doi: 10.3969/j.issn.1672-2531.2008.02.012. - DOI
    1. Cappellini MD, Farmakis D, Porter J, et al. 2021 Guidelines for the management of transfusion dependent thalassaemia (TDT) Thalassaemia international federation. 2021. - PubMed
    1. 张 俊武, 龙 桂芳. 血红蛋白与血红蛋白病[M] 南宁: 广西科学技术出版社; 2003. p. 3.
    1. Yardumian A, Telfer P, Darbyshire P. Standards for the clinical care of children and adults with thalassaemia in the UK[M] 2nd ed. London: United Kingdom Thalassaemia Society; 2008.
    1. Tanner MA, Galanello R, Dessi C, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance[J] Circulation. 2007;115(14):1876–1884. doi: 10.1161/CIRCULATIONAHA.106.648790. - DOI - PubMed

Publication types